pCPA Archives

Please find below previous updates on the status of pan-Canadian Pharmaceutical Alliance drug negotiations.

2020

As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

2019

As of December 31
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of November 30
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of October 31
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of September 30
Active drug product negotiations
Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of August 31
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of July 31
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of June 30
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of March 31
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of February 28
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of January 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

2018

As of December 31
• 
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of July 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of January 31
• 
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

2017

As of December 31
 Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of November 30
• 
Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of September 30
 Active drug product negotiations
• Complete and closed drug product negotiations
 No negotiations
• Product negotiations being considered by each province/territory

As of August 31 
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of July 31 
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of June 30 
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of May 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of April 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of March 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of February 28
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of January 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

2016

As of December 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of November 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of October 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of September 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of August 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of July 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of June 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of May 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of April 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of March 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of February 29
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of January 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

2015

As of December 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of November 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of October 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of September 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of August 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of July 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of June 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of May 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of April 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of March 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of February 28
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of January 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

2014

As of December 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of November 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of October 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of September 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of August 31 
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory

As of July 31 
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of June 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of May 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of April 30
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of April 1
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of February 28
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory

As of January 31
Active drug product negotiations
Complete and closed drug product negotiations
No negotiations
Product negotiations being considered by each province/territory